Key result
Urinary screening for chronic kidney disease in children remains controversial due to uncertainty regarding its effectiveness in preventing progression to end-stage renal disease.
Why the study?
Does urinary screening for CKD in children lead to effective interventions and reduction in progression to ESRD?
Does urinary screening for CKD in children lead to effective interventions and reduction in progression to ESRD?
The review highlights the ongoing debate and regional differences in the adoption of mass urinary screening for CKD in children.
Does not support routine urinary screening for CKD in children; leaves open its effectiveness in preventing ESRD.
This review addresses the relevance of urinary screening for chronic kidney disease (CKD) in children. Ambiguity about screening children exists because of the uncertainty as to whether early detection of renal disorders in childhood will lead to effective interventions and reduction in the number of individuals who subsequently progress to ESRD. A related concern is whether the adoption of urinary screening programs is cost effective. The most common method that is used for screening children for CKD involves the measurement of spot samples of urine for hematuria and or proteinuria. Although mass screening is now well established in Japan, Taiwan, and Korea, there appears to be movement away from mass screening to detect CKD in children and adolescents in North America and Europe. In December 2007, the American Academy of Pediatrics published their latest recommendations, in which no urinalyses were recommended at any age during childhood. The second issue addressed in this review is the reporting of estimated glomerular filtration rates (GFR) in children by clinical laboratories.
No takes yet. Share an insight, caveat, or question.
Ronald J. Hogg (2008) conducted a review in chronic kidney disease (CKD). urinary screening was evaluated. Urinary screening for chronic kidney disease in children remains controversial due to uncertainty regarding its effectiveness in preventing progression to end-stage renal disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: